Company / Book Value per Share
Taysha Gene Therapies, Inc. Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.205
FY2025
5-year range
$0.015 / $2.533
FY2021-FY2025
Trend
+200.6%
vs FY2024
Sector context
#163 of 209
Health Care
What the data says
Book Value per Share changed +201% YoY in FY2025, a notable deviation from the 5-year average annual change of +517%.
Based on SEC 10-K filings.
$1.205 in FY2025 with a 5-year CAGR of -39.0%.
Improved from $0.015 to $1.205 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -21.4%
- 5-Year CAGR
- -39.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 209This company $1.205 Sector average $189.406
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -39.0%, indicating a declining trend.
- In FY2025, book value per share increased 200.6% year-over-year.
- Ranks #163 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.205 | +200.6% |
| FY2024 | $0.401 | +2569.6% |
| FY2023 | $0.015 | -99.4% |
| FY2022 | $2.479 | -2.1% |
| FY2021 | $2.533 | -82.2% |
| FY2020 | $14.225 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026